Phase 1 Safety and Immunogenicity Evaluation of a Multiclade HIV‐1 Candidate Vaccine Delivered by a Replication‐Defective Recombinant Adenovirus VectorAndrew Catanzaro, Barney S. Graham, Mary E. Enama et al.|The Journal of Infectious Diseases|2006Cited by 318
A replication defective recombinant Ad5 vaccine expressing Ebola virus GP is safe and immunogenic in healthy adultsJulie E. Ledgerwood, Barney S. Graham, Pamela Costner et al.|Vaccine|2010Cited by 211